Ascendis Pharma Change in Accounts Payable 2015-2025 | ASND
Ascendis Pharma change in accounts payable for the twelve months ending March 31, 2025 was $-0.045B, a 651.66% decline year-over-year.
- Ascendis Pharma annual change in accounts payable for 2024 was $0.029B, a 659.28% increase from 2023.
- Ascendis Pharma annual change in accounts payable for 2023 was $0.004B, a 92.06% decline from 2022.
- Ascendis Pharma annual change in accounts payable for 2022 was $0.048B, a 4.41% increase from 2021.